ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
54 announcements with these filters
BCP Asia II Topco IV and PACs increased their stake in Aster DM Quality Care from 2.69% to 29.71%. The acquisition followed a court-sanctioned Scheme of Amalgamation.
Aster DM allotted 35,35,51,410 equity shares following its merger with Quality Care India Limited. Total paid-up capital increased to Rs.871.67 Crore.
ICRA upgraded Aster DM Quality Care's long-term rating to [ICRA]AA (Stable) from [ICRA]A+. The rating agency also reaffirmed the short-term rating at [ICRA]A1+.
BCP Asia II Topco IV Pte. Ltd acquired a 27.02% stake in Aster DM Quality Care via amalgamation. Its total holding increased to 29.71% following the scheme.
Aster DM Healthcare updated contact details for its Key Managerial Personnel. This ensures streamlined communication for determining event materiality.
Aster DM Healthcare announced multiple changes to its Board and senior management. These include several new director appointments and executive resignations effective July 1, 2026.
Aster DM Healthcare announced the effective date of its amalgamation with Quality Care India Limited. The merger includes promoter category changes and MoA amendments.
Aster DM Healthcare acquired 3,57,143 OCRPS in associate company Alfaone Medicals. The total acquisition cost was ₹25 Crore.
Aster DM Healthcare’s Board approved the NCLT amalgamation with Quality Care India on 25‑June‑2026. Record date set for 9‑July‑2026; exchange ratio 977:1,000 Aster shares.
Aster DM's subsidiary ADMPL allotted CCPS to investors on a preferential basis. The parent's stake will remain above 75% post-conversion, ensuring continued control.
Aster DM Healthcare announced a major merger with Blackstone-backed Quality Care (QCIL) to create a top-3 Indian hospital chain with 10,623 beds and ₹9,273 Cr proforma revenue.
Aster DM Healthcare reported strong Q4 FY26 performance with proforma revenue growing 18% YoY and EBITDA 25%, driven by volume growth and margin expansion ahead of its merger with Quality Care.
Aster DM delivered 18% YoY revenue growth in Q4FY26 reaching ₹1,182 Cr. Post-merger with QCIL, the combined proforma revenue hit ₹2,361 Cr with a focus on bed capacity expansion and operational efficiencies.
Aster DM Healthcare reported Q4FY26 revenue of ₹1,182 Cr (up 18%) and Operating EBITDA of ₹244 Cr (up 26%). Strategy focuses on merger with QCIL and major bed capacity expansion.
Aster DM Healthcare reported Q4 FY26 proforma revenue of ₹2,361 Crore, up 18% YoY, with operating EBITDA increasing 25% to ₹517 Crore. The merger with Quality Care India Limited (QCIL) received 96.68% shareholder approval. The combined entity's capacity will exceed 10,623 beds, positioning it among India's top three healthcare providers.
Aster DM Quality Care Ltd reported revenue from operations of ₹1,182 Cr (+18.2% YoY) and net profit of ₹153.6 Cr (+79.6% YoY) for Q4 FY26.
Aster DM Healthcare Ltd approved its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Statutory auditors Deloitte Haskins & Sells issued an unmodified opinion. The Board also previously distributed an interim dividend of ₹3 per share during the year.
Aster DM Healthcare Ltd has scheduled a Board of Directors meeting on April 30, 2026. The board will consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Aster DM Healthcare Limited and its subsidiary MIMS completed a 26% stake acquisition in Oyster Green Hybrid Two Private Limited for ₹5.80 Crore. The investment was revised from ₹7 Crore due to lower project costs. The acquisition facilitates a captive 18 MWp solar power plant in Kerala to meet the group's renewable energy requirements.
Aster DM Healthcare Limited announced the approval of special resolutions via postal ballot with a requisite majority. The resolutions include the appointment of Dr. Mandayapurath Azad Moopen as Executive Director and approval for granting loans or providing securities under Section 185. Both items were passed on April 12, 2026.
Aster DM Healthcare reported a revenue loss of ₹5.78 Crore due to a nurse strike across its Kerala hospitals. Operations have now resumed at full capacity as nursing staff returned to work following High Court intervention. The company continues to engage with the United Nurses Association to reach a final wage settlement.
Aster DM Healthcare invested ₹96 Crore to expand its 'Women & Children' facility at Aster Whitefield Hospital, Bengaluru. The expansion adds 159 beds, increasing the hospital's total capacity to 539 beds. This move strengthens Aster's regional footprint in Karnataka, bringing its total state capacity to 2,573 beds.
Aster DM Quality Care Ltd reported net profit of ₹58.6 Cr (-9.0% YoY) for Q3 FY26.
Aster DM Healthcare Limited submitted its compliance certificate under SEBI (Depositories and Participants) Regulations for the quarter ended March 31, 2026. The registrar, MUFG Intime India, confirmed that securities received for dematerialisation were processed and listed on relevant stock exchanges within prescribed timelines.